CyberKnife^® Robotic Radiosurgery system for tumor treatment

References

• Leksell DG. Stereotactic radiosurgery. Present status and future trends. Neurol. Res.9(2), 60–68 (1987).
   PubMedGoogle Scholar
• Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir. Scand.102(4), 316–319 (1951).
   PubMedGoogle Scholar
• Heck B, Jess-Hempen A, Kreiner HJ, Schopgens H, Mack A. Accuracy and stability of positioning in radiosurgery: long-term results of the gamma knife system. Med. Phys.34(4), 1487–1495 (2007).
   Google Scholar
• Ho AK, Fu D, Cotrutz C et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery60(2 Suppl. 1), 147–156 (2007).
   Google Scholar
• Collins SP, Coppa ND, Zhang Y, Collins BT, McRae DA, Jean WC. CyberKnife radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters. Rad. Oncol.1, 46 (2006).
   Google Scholar
• Robotic Radiosurgery. Urschel HC (Ed.). Springer, Berlin, Germany, (2007) 1–36.
   Google Scholar
• Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for meningiomas. Neurosurg. Clin. N. Am.10(2), 317–325 (1999).
   PubMedGoogle Scholar
• Lunsford LD, Flickinger J, Lindner G, Maitz A. Stereotactic radiosurgery of the brain using the first United States 201 cobalt-60 source gamma knife. Neurosurgery24(2), 151–159 (1989).
   PubMed Web of Science ®Google Scholar
• Lunsford LD, Kondziolka D, Flickinger JC. Stereotactic radiosurgery for benign intracranial tumors. Clin. Neurosurg.40, 475–497 (1993).
   Google Scholar
• Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J. Neurosurg.98(2), 342–349 (2003).
   PubMed Web of Science ®Google Scholar
• Colombo F, Pozza F, Chierego G, Casentini L, De Luca G, Francescon P. Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update. Neurosurgery34(1), 14–21 (1994).
   PubMed Web of Science ®Google Scholar
• Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet363(9422), 1665–1672 (2004).
   PubMed Web of Science ®Google Scholar
• Sneed PK, Suh JH, Goetsch SJ et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int. J. Radiat. Oncol. Biol. Phys.53(3), 519–526 (2002).
   PubMed Web of Science ®Google Scholar
• Chang SD, Lee E, Sakamoto GT, Brown NP, Adler JR Jr. Stereotactic radiosurgery in patients with multiple brain metastases. Neurosurg. Focus9(2), E3 (2000).
   Google Scholar
• Adler JR Jr, Gibbs IC, Puataweepong P, Chang SD. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery59(2), 244–254 (2006).
   PubMed Web of Science ®Google Scholar
• Chopra R, Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int. J. Radiat. Oncol. Biol. Phys.68(3), 845–851 (2007).
   PubMed Web of Science ®Google Scholar
• Chang SD, Gibbs IC, Sakamoto GT, Lee E, Oyelese A, Adler JR Jr. Staged stereotactic irradiation for acoustic neuroma. Neurosurgery56(6), 1254–1263 (2005).
   PubMed Web of Science ®Google Scholar
• Degen JW, Gagnon GJ, Voyadzis JM et al. CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J. Neurosurg. Spine2(5), 540–549 (2005).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C. CyberKnife radiosurgery for spinal neoplasms. Prog. Neurol. Surg.20, 340–358 (2007).
   PubMedGoogle Scholar
• Gerszten PC, Welch WC. Cyberknife radiosurgery for metastatic spine tumors. Neurosurg. Clin. N. Am.15(4), 491–501 (2004).
   PubMed Web of Science ®Google Scholar
• Gibbs IC, Kamnerdsupaphon P, Ryu MR et al. Image-guided robotic radiosurgery for spinal metastases. Radiother. Oncol.82(2), 185–190 (2007).
   PubMed Web of Science ®Google Scholar
• De Salles AA, Pedroso AG, Medin P et al. Spinal lesions treated with Novalis shaped beam intensity-modulated radiosurgery and stereotactic radiotherapy. J. Neurosurg.101(Suppl. 3), 435–440 (2004).
   PubMed Web of Science ®Google Scholar
• Ryu S, Fang Yin F, Rock J et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer97(8), 2013–2018 (2003).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine32(2), 193–199 (2007).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact. Funct. Neurosurg.83(5–6), 213–221 (2005).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Welch WC et al. Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer104(10), 2244–2254 (2005).
   PubMed Web of Science ®Google Scholar
• Jin JY, Chen Q, Jin R et al. Technical and clinical experience with spine radiosurgery: a new technology for management of localized spine metastases. Technol. Cancer Res. Treat.6(2), 127–133 (2007).
   Google Scholar
• Chang EL, Shiu AS, Lii MF et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int. J. Radiat. Oncol. Biol. Phys.59(5), 1288–1294 (2004).
   PubMed Web of Science ®Google Scholar
• Dodd RL, Ryu MR, Kamnerdsupaphon P, Gibbs IC, Chang SD Jr, Adler JR Jr. CyberKnife radiosurgery for benign intradural extramedullary spinal tumors. Neurosurgery58(4), 674–685 (2006).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Ozhasoglu C, Burton SA et al. CyberKnife frameless single-fraction stereotactic radiosurgery for benign tumors of the spine. Neurosurg. Focus14(5), E16 (2003).
   Google Scholar
• Sinclair J, Chang SD, Gibbs IC, Adler JR Jr. Multisession CyberKnife radiosurgery for intramedullary spinal cord arteriovenous malformations. Neurosurgery58(6), 1081–1089 (2006).
   Google Scholar
• Bangalore M, Matthews S, Suntharalingam M. Recent advances in radiation therapy for head and neck cancer. ORL J. Otorhinolaryngol. Relat. Spec.69(1), 1–12 (2007).
   Google Scholar
• Cmelak AJ, Cox RS, Adler JR, Fee WE Jr, Goffinet DR. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.37(5), 997–1003 (1997).
   PubMedGoogle Scholar
• Gardner E, Linskey ME, Penagaricano JA, Hanna EY. Stereotactic radiosurgery for patients with cancer of the head and neck. Curr. Oncol. Rep.5(2), 164–169 (2003).
   Google Scholar
• Pai PC, Chuang CC, Wei KC, Tsang NM, Tseng CK, Chang CN. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck24(8), 748–753 (2002).
   PubMed Web of Science ®Google Scholar
• Ryu S, Khan M, Yin FF et al. Image-guided radiosurgery of head and neck cancers. Otolaryngol. Head Neck Surg.130(6), 690–697 (2004).
   Google Scholar
• Voynov G, Heron DE, Burton S et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol. Cancer Res. Treat.5(5), 529–535 (2006).
   PubMed Web of Science ®Google Scholar
• Le QT, Tate D, Koong A et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.56(4), 1046–1054 (2003).
   PubMed Web of Science ®Google Scholar
• Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J. Clin. Oncol.25(8), 947–952 (2007).
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Sengelov L et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother. Oncol.76(1), 48–53 (2005).
   PubMed Web of Science ®Google Scholar
• Koong AC, Christofferson E, Le QT et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys.63(2), 320–323 (2005).
   PubMed Web of Science ®Google Scholar
• Koong AC, Le QT, Ho A et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys.58(4), 1017–1021 (2004).
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol.34(6), 861–870 (1995).
   PubMed Web of Science ®Google Scholar
• Kavanagh BD, Schefter TE, Cardenes HR et al. Interim analysis of a prospective Phase I/II trial of SBRT for liver metastases. Acta Oncol.45(7), 848–855 (2006).
   PubMed Web of Science ®Google Scholar
• Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int. J. Radiat. Oncol. Biol. Phys.62(5), 1371–1378 (2005).
   PubMed Web of Science ®Google Scholar
• Wulf J, Guckenberger M, Haedinger U et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol.45(7), 838–847 (2006).
   PubMed Web of Science ®Google Scholar
• Goodman KA, Anderson E, Maturen K et al. Phase I dose escalation study of CyberKnife stereotactic radiosurgery for liver malignancies (poster presentation). Proceedings of the ASCO 2006 Gastrointestinal Cancers Symposium. San Francisco, CA, USA 26–28 January 2006.
   Google Scholar
• Onishi H, Araki T, Shirato H et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer101(7), 1623–1631 (2004).
   PubMed Web of Science ®Google Scholar
• Onishi H, Shirato H, Nagata Y et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J. Thorac. Oncol.2(7 Suppl. 3), S94–S100 (2007).
   PubMed Web of Science ®Google Scholar
• Le QT, Loo BW, Ho A et al. Results of a Phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J. Thorac. Oncol.1(8), 802–809 (2006).
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue. Int. J. Radiat. Oncol. Biol. Phys.52(1), 6–13 (2002).
   PubMed Web of Science ®Google Scholar
• Fowler J, Chappell R, Ritter M. Is α/β for prostate tumors really low? Int. J. Radiat. Oncol. Biol. Phys.50(4), 1021–1031 (2001).
   PubMed Web of Science ®Google Scholar
• Lloyd-Davies RW, Collins CD, Swan AV. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years’ experience (1962–1984). Urology36(2), 107–111 (1990).
   Google Scholar
• Martinez AA, Pataki I, Edmundson G, Sebastian E, Brabbins D, Gustafson G. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int. J. Radiat. Oncol. Biol. Phys.49(1), 61–69 (2001).
   PubMed Web of Science ®Google Scholar
• Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int. J. Radiat. Oncol. Biol. Phys.67(4), 1099–1105 (2007).
   PubMed Web of Science ®Google Scholar
• Jo MK, Park K, Kim KH, Cho CG, Lee C. Feasibility of Cyberknife for localized prostate cancer: preliminary results. Presented at: American Urologic Association Annual Meeting. Atlanta, GA, USA, 20–25 May 2006.
   Google Scholar
• Hara W, Patel D, Pawlicki T, Cotrutz C, Presti J, King C. Hypofractionated stereotactic radiotherapy for prostate cancer: early results. Int. J. Radiat. Oncol. Biol. Phys.66(3), S324–S325 (2006).
   Google Scholar
• Moertel CG, Frytak S, Hahn RG et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group. Cancer48(8), 1705–1710 (1981).
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Group. J. Natl Cancer Inst.80(10), 751–755 (1988).
   Google Scholar
• McGinn CJ, Zalupski MM. Combined-modality therapy in pancreatic cancer: current status and future directions. Cancer J.7(4), 338–348 (2001).
   Google Scholar
• Chang S, Goodman KA, Quon A et al. Phase II study to assess the efficacy of gemcitabine chemotherapy followed by stereotactic body radiotherapy (SBRT) in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys.66, S295–S296 (2006).
   Google Scholar
• Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg.60(3), 615–623 (1995).
   PubMed Web of Science ®Google Scholar
• Uematsu M, Shioda A, Suda A et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int. J. Radiat. Oncol. Biol. Phys.51(3), 666–670 (2001).
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int. J. Radiat. Oncol. Biol. Phys.60(1), 186–196 (2004).
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y et al. Clinical outcomes of a Phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys.63(5), 1427–1431 (2005).
   PubMed Web of Science ®Google Scholar
• Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol.24(30), 4833–4839 (2006).
   PubMed Web of Science ®Google Scholar